Drug intelligence / Profile preview

adapalene + benzoyl peroxide + doxycycline

Development stage
Unknown
Lead developer
Galderma
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

**adapalene + benzoyl peroxide + doxycycline** is a combination drug regimen used for the treatment of severe acne vulgaris. It consists of adapalene, a third-generation topical retinoid with comedolytic and anti-inflammatory properties; benzoyl peroxide, a topical antimicrobial agent; and doxycycline, an oral tetracycline-class antibiotic that inhibits bacterial protein synthesis and decreases inflammation. This combination targets multiple pathogenic factors in acne, including abnormal keratinization, Propionibacterium acnes colonization, and inflammation. Clinical studies have shown the combination is more effective than either agent alone in reducing total, inflammatory, and non-inflammatory acne lesions, and is considered a cost-effective and safer alternative to oral isotretinoin in certain severe cases[1][3][5][7].

Brand names
EpiduoEpiduo ForteOracea
Other names
adapalene and benzoyl peroxide gel with doxycyclineA-BPO/D
02

Targets

Bacterial RibosomeRARG (Retinoic acid receptor gamma)

Beyond the preview

Go deeper on adapalene + benzoyl peroxide + doxycycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adapalene + benzoyl peroxide + doxycycline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call